VectivBio (VECT) Competitors $16.85 0.00 (0.00%) As of 04/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock VECT vs. MTSR, RXRX, AMRX, TWST, APLS, BHVN, DNLI, VCEL, MIRM, and BHCShould you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Metsera (MTSR), Recursion Pharmaceuticals (RXRX), Amneal Pharmaceuticals (AMRX), Twist Bioscience (TWST), Apellis Pharmaceuticals (APLS), Biohaven (BHVN), Denali Therapeutics (DNLI), Vericel (VCEL), Mirum Pharmaceuticals (MIRM), and Bausch Health Companies (BHC). These companies are all part of the "pharmaceutical products" industry. VectivBio vs. Metsera Recursion Pharmaceuticals Amneal Pharmaceuticals Twist Bioscience Apellis Pharmaceuticals Biohaven Denali Therapeutics Vericel Mirum Pharmaceuticals Bausch Health Companies VectivBio (NASDAQ:VECT) and Metsera (NASDAQ:MTSR) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership. Is VECT or MTSR more profitable? Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A Metsera N/A N/A N/A Which has stronger valuation and earnings, VECT or MTSR? Metsera has lower revenue, but higher earnings than VectivBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/AMetseraN/AN/AN/AN/AN/A Does the MarketBeat Community believe in VECT or MTSR? VectivBio received 6 more outperform votes than Metsera when rated by MarketBeat users. However, 100.00% of users gave Metsera an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% MetseraOutperform Votes4100.00% Underperform VotesNo Votes Do analysts prefer VECT or MTSR? Metsera has a consensus target price of $47.00, suggesting a potential upside of 94.94%. Given Metsera's stronger consensus rating and higher possible upside, analysts plainly believe Metsera is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Metsera 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor VECT or MTSR? In the previous week, Metsera had 5 more articles in the media than VectivBio. MarketBeat recorded 5 mentions for Metsera and 0 mentions for VectivBio. Metsera's average media sentiment score of 0.67 beat VectivBio's score of 0.00 indicating that Metsera is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral Metsera Positive SummaryMetsera beats VectivBio on 6 of the 8 factors compared between the two stocks. Get VectivBio News Delivered to You Automatically Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VECT vs. The Competition Export to ExcelMetricVectivBioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$573.24M$3.00B$5.56B$7.83BDividend YieldN/A1.89%5.11%4.22%P/E RatioN/A30.4222.4418.48Price / Sales20.97498.92393.95103.59Price / CashN/A168.6838.1834.62Price / BookN/A3.206.774.25Net Income-$93.74M-$72.35M$3.22B$248.23M7 Day PerformanceN/A1.46%1.45%0.89%1 Month PerformanceN/A8.79%3.96%3.53%1 Year PerformanceN/A-22.36%16.07%5.08% VectivBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeMTSRMetseraN/A$21.68+11.1%$47.00+116.8%N/A$2.28BN/A0.0081News CoverageRXRXRecursion Pharmaceuticals2.213 of 5 stars$5.63+4.1%$8.20+45.6%-28.5%$2.26B$58.49M-3.68400Upcoming EarningsAMRXAmneal Pharmaceuticals3.3494 of 5 stars$7.25+1.7%$10.80+49.0%+26.6%$2.25B$2.79B-10.667,600News CoveragePositive NewsTWSTTwist Bioscience3.6172 of 5 stars$36.94+6.9%$52.80+42.9%+22.7%$2.20B$330.19M-10.93990Upcoming EarningsPositive NewsAPLSApellis Pharmaceuticals4.1182 of 5 stars$17.37-3.7%$45.35+161.1%-56.5%$2.18B$781.37M-8.56770Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageBHVNBiohaven3.6265 of 5 stars$21.10+2.7%$62.77+197.5%-43.0%$2.15BN/A-2.26239Upcoming EarningsAnalyst ForecastDNLIDenali Therapeutics4.1568 of 5 stars$14.60+11.0%$37.57+157.3%+7.8%$2.12B$330.53M-5.29430Upcoming EarningsPositive NewsVCELVericel2.3127 of 5 stars$39.42-3.5%$60.86+54.4%-17.1%$1.98B$237.22M657.11300Upcoming EarningsNews CoveragePositive NewsMIRMMirum Pharmaceuticals4.2437 of 5 stars$39.43+2.7%$58.20+47.6%+73.0%$1.95B$336.89M-19.52140Upcoming EarningsNews CoveragePositive NewsBHCBausch Health Companies4.1743 of 5 stars$5.20+10.1%$7.17+38.0%-39.7%$1.91B$9.63B-43.2919,900Analyst UpgradeNews Coverage Related Companies and Tools Related Companies MTSR Alternatives RXRX Alternatives AMRX Alternatives TWST Alternatives APLS Alternatives BHVN Alternatives DNLI Alternatives VCEL Alternatives MIRM Alternatives BHC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VECT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VECT Stock Free VECT Stock Alerts